Journal article
The cost implications of a polypill for primary prevention in the TIPS-3 trial
Abstract
AIMS: The International Polycap Study 3 (TIPS-3) trial demonstrated that a polypill containing cholesterol- and multiple blood-pressure-lowering drugs reduces cardiovascular events by 20% compared with placebo in people without cardiovascular disease. The polypill plus aspirin led to a 31% relative risk reduction in cardiovascular disease events compared with double placebo. We report regional variations in costs and affordability of a polypill …
Authors
Lamy A; Tong W; Joseph P; Gao P; Pais P; Lopez-Jaramillo P; Walli-Attaei M; Dans AL; Xavier D; Talukder S
Journal
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 8, No. 8, pp. 899–908
Publisher
Oxford University Press (OUP)
Publication Date
November 17, 2022
DOI
10.1093/ehjqcco/qcab101
ISSN
2058-5225